A detailed history of Edmond De Rothschild Holding S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 26,495 shares of ABBV stock, worth $4.37 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
26,495
Previous 16,970 56.13%
Holding current value
$4.37 Million
Previous $2.91 Million 79.79%
% of portfolio
0.09%
Previous 0.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $1.56 Million - $1.9 Million
9,525 Added 56.13%
26,495 $5.23 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $486,040 - $567,586
-3,140 Reduced 15.61%
16,970 $2.91 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $748,756 - $853,138
-4,685 Reduced 18.89%
20,110 $3.66 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $424,908 - $478,547
-3,088 Reduced 11.07%
24,795 $3.84 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $241,530 - $279,607
1,808 Added 6.93%
27,883 $4.16 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $1.51 Million - $1.88 Million
11,424 Added 77.97%
26,075 $3.51 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $2.17 Million - $2.5 Million
-14,988 Reduced 50.57%
14,651 $2.33 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $343,285 - $411,689
2,482 Added 9.14%
29,639 $4.79 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $83,075 - $95,282
619 Added 2.33%
27,157 $3.64 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $591,766 - $752,328
4,300 Added 19.34%
26,538 $4.06 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $1.25 Million - $1.55 Million
9,474 Added 74.22%
22,238 $3.61 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $469,146 - $593,606
4,367 Added 52.01%
12,764 $1.73 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $151,194 - $171,628
1,421 Added 20.37%
8,397 $906,000
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $9,994 - $11,134
95 Added 1.38%
6,976 $786,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $239,382 - $263,530
2,340 Added 51.53%
6,881 $744,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $69,704 - $94,108
-866 Reduced 16.02%
4,541 $486,000
Q2 2020

Aug 07, 2020

SELL
$73.37 - $98.18 $158,259 - $211,774
-2,157 Reduced 28.52%
5,407 $530,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $144,260 - $180,500
-2,000 Reduced 20.91%
7,564 $670,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $496,954 - $635,224
7,564 Added 378.2%
9,564 $695,000
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $339,801 - $399,929
-4,405 Reduced 68.77%
2,000 $161,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $29,972 - $36,963
-385 Reduced 5.67%
6,405 $590,000
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $126,430 - $140,550
1,422 Added 26.49%
6,790 $642,000
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $69,007 - $92,407
-750 Reduced 12.26%
5,368 $507,000
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $17,912 - $19,642
-200 Reduced 3.17%
6,118 $591,000
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $441,312 - $563,691
6,318
6,318 $561,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.